# Artery Elasticity After Switch From Epzicom to Truvada

> **NCT00998582** · PHASE4 · TERMINATED · sponsor: **Hennepin Healthcare Research Institute** · enrollment: 27 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Tenofovir disoproxil

## Key facts

- **NCT ID:** NCT00998582
- **Lead sponsor:** Hennepin Healthcare Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2011-06
- **Final completion:** 2011-12
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2012-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00998582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00998582, "Artery Elasticity After Switch From Epzicom to Truvada". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00998582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*